Objective To investigate the predictive value of thrombospondin-2 (TSP-2) in assessing the response to intravenous immunoglobulin (IVIG) in children with acute Kawasaki disease (KD).
What is already known on this topic?
Thrombospondins (TSPs), extracellular matrix glycoprotein, have been implicated in regulating cardiovascular inflammation and immune response.
Our previous study found that plasma TSP-2 concentration elevated in Kawasaki disease patients with coronary artery abnormalities.
What this study adds?
TSP-2 might be a useful biomarker for predicting responsiveness to intravenous immunoglobulin (IVIG) during the acute phase of KD. immunoglobulin (IVIG) and aspirin has decreased the incidence of CAA to 3-5%. 1 However, not all patients respond to IVIG, estimates range from 14.3%-28.9% of children in the United States, 2 20.3% of cases in Japan, 3 and 9.9% in China. 4 Coronary artery lesions are more likely in children who are unresponsive or insensitive to IVIG treatment. 5 Therefore, the identification of biomarkers for IVIG responsive patients and the selection of appropriate initial treatment strategies are critical to prevent and reduce the occurrence of coronary artery lesions and CAA.
The thrombospondin (TSP) family is constituted of 5 members, TSP-1 to TSP-5, subdivided in 2 groups based on their oligomerization domain and size. 6 TSP-1 and TSP-2 are from the group A and have been implicated in regulating cardiovascular inflammation and the immune response, and maintaining the integrity and function of cardiac structures. [7] [8] [9] However, changes in TSP levels and their relationship to therapeutic response in KD remain unclear. Therefore, the purpose of this study was to investigate the level of plasma TSP-2 and TSP-1 in children with KD and determine whether TSP-2 can serve as biomarkers to predict the IVIG therapeutic response in KD children.
METHODS

Study participants
The study was a retrospective case-control analysis. From May 2013 to August 2014 children newly diagnosed with KD at Children's Hospital Capital Institute of Pediatrics were enrolled in the study. The KD diagnosis was based on 5 th edition diagnostic criteria revised by the Japanese KD Research Committee. 10 Briefly, tip; (6) acute non-suppurative cervical lymphadenopathy that was often unilateral, diameter greater than 1.5 cm.
KD was diagnosed if patients presented with five or more of the criteria. KD was also diagnosed in patients who met four of the criteria and had a coronary artery aneurysms or coronary artery ectasia observable by two-dimensional echocardiogram or coronary arteriography. The exclusion criteria were: (1) relapsing KD; (2) the initial treatment failure and readmission of KD patients; and (3) the presence of other vascular inflammatory diseases.
Children diagnosed with KD were administered with standard therapy, which consisted of IVIG (2g/kg·d) (approximately 6th-9th days after fever onset) and acetylsalicylic acid (ASA) (30 -50 mg/kg·d until 48-72 hours after returning to normal temperature). Non-responders were defined as: (1) continued fever (>38.0°C) 36h after IVIG infusion; or (2) recurrent fever within 7 days after IVIG infusion, accompanied by other clinical manifestations of KD.
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Two control populations were recruited, patients with a fever and healthy subjects without a fever. The febrile control group included patients with respiratory tract infections (upper respiratory infections, bronchitis, pneumonia, etc.) who were hospitalized in the same period. Patients with cardiovascular disease, vascular inflammation and autoimmunity-related diseases who presented with a fever lasting for 3-5 days were excluded after a medical history examination, physical examination, and laboratory examination. The healthy controls had no abnormality on physical examination, and had no reported KD, cardiovascular diseases, vascular inflammatory disease, or autoimmune disease in their medical history in the department of Child Healthcare of (Figure 1) .
Comparison of the TSP-2 and TSP-1 between the IVIG response group and the IVIG non-response group
The plasma concentration of TSP-2 was significantly elevated in the IVIG non-responders compared to in the The ROC curve of TSP-2 to predict IVIG non-response
In the present study, the plasma concentration of TSP-2 was significantly elevated in the IVIG non-responders compared to the IVIG responders. A ROC curve was used to determine whether the plasma TSP-2 concentration predicted whether a patient would be an IVIG non-responder. The AUC was 0.752 (95%CI:
0.630 to 0.875; P=0.002). When the cutoff value for TSP-2 was 31.50 ng/ml, the sensitivity was 82.35%, the specificity was 64.81% ( Figure 3) .
DISCUSSION
Approximately 15% -25% of KD patients do not respond to the standard regimen of oral aspirin and IVIG. 12 Predicting the therapeutic response of KD patients to the standard treatment regimen in the early phase of the disease is critical in preventing and treating coronary injury and has gained momentum in recent years.
Kobayashi et al. proposed predicting IVIG insensitivity using the PLT, neutrophil percentage, C-reactive protein, and other scores. 13 Others have suggested using changes in IL-4, IL-6, IL-10, and TNF-α to predict IVIG responsiveness before and after using IVIG. 14 However, currently, there is no definitive biomarker that can predict the therapeutic response of children with KD during the acute phase.
We have previously reported that plasma levels of TSP-2 and TSP-1 were significantly increased in children with KD children presenting with coronary artery dilatation. 15 Here, we show that in the acute phase of KD, the plasma TSP-2 and TSP-1 concentration was significantly elevated relative to healthy control and patients with an unrelated fever. The TSP-2 concentration in IVIG non-responders was significantly higher than in IVIG responders. To examine the possible predictive value of plasma levels of TSP-2 for the responsiveness of IVIG therapy, we used ROC analysis and chose the cutoff value as 31.50ng/ml, so that the Youden index attained its maximum. The results showed that plasma levels of TSP-2 had both higher sensitivity (82.35%) and specificity The present study has some limitations. Firstly, the amount of patients might be relatively small and all specimens were only collected from one hospital. However, considering the occurrence rate [2] [3] [4] of IVIG resistance and the feature of this retrospective study, it was hardly to collect affluent samples in a short term. We hope that this finding will lead to more attention and inspiration, so that more investigations and clinical trials from multicenter will be conducted to validate these results. Secondly, the levels of TSP-2 were not correlated with other known parameters, such as clinical manifestations and laboratory indicators, and if these elements were added, the predicting effect might be improved.
In conclusion, the plasma concentration of TSP-2 might serve as a useful indicator for predicting the risk of IVIG nonresponse in KD children before starting treatment and help pediatricians planning individualized initial therapy regimens. 
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The ROC curve of TSP-2 to predict IVIG non-response
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In the present study, the plasma concentration of TSP-2 was significantly elevated in the IVIG 
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DISCUSSION
16
Approximately 15% -25% of KD patients do not respond to the standard regimen of oral aspirin and IVIG. 12 Predicting the therapeutic response of KD patients to the standard treatment regimen in the early phase of the 18 disease is critical in preventing and treating coronary injury and has gained momentum in recent years. established by these indicators were deficiently precise to be clinically applied to our population. Therefore, we 6 speculate that some other factors might have not been found in regard to the IVIG therapeutic response of 7 children with KD during the acute phase. Cytokines, also have been reported as early predictor for IVIG 8 non-responders 15, 16 . Nevertheless, some patients with other diseases can also be observed with a high level of 9 cytokines before treatment, such as bacterial infections, pneumonia and sepsis, sometimes even "cytokine storms" 10 occurring after infection. Therefore, cytokines are not stable and specific biomarkers for assessing the severity of 11 KD. In view of these reasons, we aimed to find a simple novel biomarker to predict the risk of IVIG resistance.
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We have previously reported that plasma levels of TSP-2 and TSP-1 were significantly increased in children
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with KD children presenting with coronary artery dilatation. 17 Here, we show that in the acute phase of KD, the 14 plasma TSP-2 and TSP-1 concentration was significantly elevated relative to healthy control and patients with an 15 unrelated fever. The TSP-2 concentration in IVIG non-responders was significantly higher than in IVIG 16 responders. To examine the possible predictive value of plasma levels of TSP-2 for the responsiveness of IVIG 17 therapy, we used ROC analysis and chose the cutoff value as 31.50ng/ml, so that the Youden index attained its 18 maximum. The results showed that plasma levels of TSP-2 had both higher sensitivity (82.35%) and specificity
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(64.81%) in predicting the non-response of IVIG for treating KD. It revealed that when the plasma level of 20 TSP-2 was higher than 31.50 ng/ml, more than 80% suspected IVIG resistant children would be recognized. The mechanism responsible for the increased TSP-2 level in KD patients of non-responders is unknown. As The present study has some limitations. Firstly, the number of patients might be relatively small and all 7 specimens were only collected from one hospital. However, considering the occurrence rate 2-4 of IVIG resistance 8 and the feature of this retrospective study, it was hardly to collect affluent samples in a short term. We hope that 9 this finding will lead to more attention and inspiration, so that more investigations and clinical trials from 10 multicenter will be conducted to validate these results. Secondly, the levels of TSP-2 were not correlated with 11 other known parameters, such as clinical manifestations and laboratory indicators, and if these elements were 12 added, the predicting effect might be improved. Thirdly, the specificity of TSP-2 was lower, which may lead to 13 misdiagnosis of some patients.
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In conclusion, the plasma concentration of TSP-2 might serve as a useful indicator for predicting the risk of 4
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